Technology

Lunit's AI Now Powers Cancer Screening for Over 14% of Italy's Population Through Public Health System

Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced a significant expansion of its footprint in Italy's public healthcare system. As of June 2025, more than 10 Local Health Authorities—commonly known as ASL (Azienda Sanitaria Locale)—are using Lunit's AI solutions to enhance cancer screening and optimize imaging workflow. These ASLs collectively serve a population of over 8.5 million, accounting for approximately 14% of Italy's total populatio

articleLunit Inc.August 26, 20253/company/lunit-inc/news/lunits-ai-now-powers-cancer-screening-for-over-14percent-of-italys-population-through-public-health-system
Lunit's AI Now Powers Cancer Screening for Over 14% of Italy's Population Through Public Health System

About this update from Lunit Inc.

[{"type":"text","content":"With deployments in Lazio, Lombardia, and Veneto regions, Lunit strengthens its foothold in one of Europe's largest public healthcare systems","length":145,"tagName":"p"},{"type":"text","content":"SEOUL, South Korea, Aug. 26, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced a significant expansion of its footprint in Italy's public healthcare system. As of June 2025, more than 10 Local Health Authorities—commonly known as ASL (Azienda Sanitaria Locale)—are using Lunit's AI solutions to enhance cancer screening and optimize imaging workflow. These ASLs collectively serve a population of over 8.5 million, accounting for approximately 14% of Italy's total population.","length":564,"tagName":"p"},{"type":"image","alt":"Lunit INSIGHT MMG being used as part of a regional breast cancer screening program in Treviso Province, Italy.","displaySize":"","headline":null,"caption":"Lunit INSIGHT MMG being used as part of a regional breast cancer screening program in Treviso Province, Italy.","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":224,"url":"https://media.zenfs.com/en/prnewswire.com/3ea79f0bfb81f1e60e0250e2019d8dda"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/oJ8EVPOoQEBDIpwx0q19xA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM5NTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/3ea79f0bfb81f1e60e0250e2019d8dda","width":400,"height":224}},"href":"https://mma.prnewswire.com/media/2757984/Lunit_INSIGHT_MMG_part_a_regional_breast_cancer_screening_program.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The deployments span multiple regions, including Lazio, Lombardia, and Veneto—three of the country's most populous and high-demand areas. Lunit's AI solutions—Lunit INSIGHT MMG for mammography and Lunit INSIGHT CXR for chest X-ray—are currently in use to support radiologists in detecting breast and lung abnormalities with greater speed and accuracy.","length":359,"tagName":"p"},{"type":"text","content":"Italy represents one of the key European markets where AI is being adopted at scale in public healthcare, demonstrating how population-wide deployment can be achieved. The growing adoption of Lunit's AI solutions within this system marks a critical milestone in the real-world ap...

More updates from Lunit Inc.

cancer screeningpublic healthcaretotal population